Pour savoir comment effectuer et gérer un dépôt de document, consultez le « Guide abrégé – Dépôt de documents » sur le site Web de la Bibliothèque. Pour toute question, écrivez à corpus@ulaval.ca.

Personne :
Selivanova, Svetlana V.

En cours de chargement...
Photo de profil

Adresse électronique

Date de naissance

Projets de recherche

Structures organisationnelles


Nom de famille



Svetlana V.


Université Laval. Faculté de pharmacie



Identifiant Canadiana



Résultats de recherche

Voici les éléments 1 - 1 sur 1
  • PublicationRestriction temporaire
    Gold-enhanced brachytherapy by a nanoparticle-releasing hydrogel and 3d-printed subcutaneous radioactive implant approach
    (Wiley-VCH Verlag GmbH & Co., 2023-04-24) Kiseleva, Mariia; Théophraste, Lescot; Selivanova, Svetlana V.; Fortin, Marc-André
    Brachytherapy (BT) is a widely used clinical procedure for localized cervical cancer treatment. In addition, gold nanoparticles (AuNPs) have been demonstrated as powerful radiosensitizers in BT procedures. Prior to irradiation by a BT device, their delivery to tumors can enhance the radiation effect by generating low-energy photons and electrons, leading to reactive oxygen species (ROS) production, lethal to cells. No efficient delivery system has been proposed until now for AuNP topical delivery to localized cervical cancer in the context of BT. This article reports an original approach developed to accelerate the preclinical studies of AuNP-enhanced BT procedures. First, a AuNP-containing hydrogel (Pluronic F127, alginate) is developed and tested in mice for degradation, AuNP release, and biocompatibility. Then, custom-made 3D-printed radioactive BT inserts covered with a AuNP-containing hydrogel cushion are designed and administered by surgery in mice (HeLa xenografts), which allows measuring AuNP penetration in tumors (~100 m), co-registered with the presence of ROS produced through the interactions of radiation and AuNPs. Overall, the application of a biocompatible AuNPs-releasing hydrogel in the vicinity of cervical cancer prior to BT could decrease the total amount of radiation needed per BT treatment, with benefits on the preservation of healthy tissues surrounding cancer.